Emerging Strategies in the Management of Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma) – Enduring Webcast
Description
Program Description
The treatment of genitourinary malignancies has dramatically evolved over recent years. Renal cell carcinoma, urothelial carcinoma of the bladder, and prostate adenocarcinoma are the commonly encountered genitourinary malignancies and represent a heterogeneous population of cancers in both histology and approach to treatment. However, all three cancers have undergone paradigm shifts in their respective therapeutic landscapes due to a greater understanding of their underlying molecular mechanisms and oncogenic drivers.
Intended Audience
This webcast is designed to meet the educational needs of hematologists/oncologists, urologists, nurse practitioners, physician assistants, and nurses involved in the care and treatment of patients with genitourinary malignancies.
Commercial Supporter
This activity is supported by an educational grant from Exelixis, Inc.
CME | CNE 2.00 Credits
Webcast
Time to Complete: 2 hours
Released: November 22, 2021
Expires: November 22, 2022
Maximum Credits:
2.00 / AMA PRA Category 1 CreditsTM
2.00 / ANCC Contact Hours
Start Activity